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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S234Results: Common among all impacted groups in comparison to CTRL
groups at every time point was the increased gene expression asso-
ciated with the IPA canonical pathway/functional category “Role of
Osteoblasts, osteoclasts and chondrocytes in Rheumatoid arthritis”
containing genes such as BMP2, BMP4, MMP13, FRZB, TNSF11, and ITGP3 .
The biological networks associated with impacts differed with impact
magnitude and time. After 24 hours, gene networks associated with
“Skeletal and Muscular system development and function, tissue
development, connective tissue disorders” (MATN3, MMP13, FGF18,
DMP1, BMP2, BMP4, COL9A1, TGFB3, etc.) were active after 17 MPa
impacts as compared to the biological network “Cellular development,
Cellular growth and proliferation, Skeletal and muscular system
development and function” (COL10A1, VCAN, WISP1, TGFB3, etc.) which
was differentially expressed after 36 MPa impacts. 36 MPa impacts also
changed the expression of genes in the “Granulocyte adhesion and
diapedesis” (CCL20, CXCL14, CXCR2, PECAM1, etc.) functional category
indicating a greater inﬂammatory response. Three days after impact,
both impact groups showed differential expression of genes in the “Cell
cycle, Cellular Assembly and organization, DNA replication, recombi-
nation and repair” group represented by genes such as CDK1, CENPE,
CENPF, MATN3, among others. Similar biological groups were also
identiﬁed 7 days after impact in the 17 MPa group with representative
genes such as BMP4, MMP13, OMD, COL10A1, COL1A1, and DMP1. In the
7-day, 36 MPa group, we observed markers such as IBSP, BAMBI, FGF7,
SP7, and POSTN.
Conclusions: While we observed differential expression of catabolic
genes such as MMP13, MMP3 and anabolic genes like COL2A1, COL1A1,
andMATN3 in most impact groups and time points, we found that each
condition was also characterized by the expression of speciﬁc sets of
genes. 24 hours after impact we noticed the expression of pro-
inﬂammatory genes (e.g. IL-6) following the high impact force. Three
days following impact, the top functional pathway identiﬁed by IPA in
both the 17MPa and the 36MPa groups contained genes involved in cell
cycle and DNA repair, suggesting the activation of a common reparatory
mechanism. At 7 days gene expression by cells in 17 and 36 MPa impact
samples diverged between chondrogenic/hypertrophic and osteogenic
functional groups. This difference may reﬂect a more advanced disease
state in the high impact group, or a different response altogether. Many
of the genes identiﬁed in this study were previously identiﬁed as
markers of OA, indicating that further validation and functional analy-
ses of novel loci identiﬁed here could lead to the development of new
PT-OA therapeutic candidates.
416
GENETIC ASSOCIATION ANALYSIS OF RADIOGRAPHIC HIP
OSTEOARTHRITIS WITH ESTABLISHED LOCI FOR BONE MINERAL
DENSITY: DATA FROM THE OSTEOARTHRITIS INITIATIVE
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D.J. Duggan k, P.M. Jungmann{, B.D. Mitchell y, R.D. Jackson#,
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Purpose: Previous studies have shown that high bone mineral density
(BMD) is associated with an increased risk of knee and hip osteo-
arthritis. We recently completed an analysis evaluating the association
of 56 established BMD loci (64 SNPs) for their association with radio-
graphic knee osteoarthritis (rKOA) and identiﬁed four genetic variants
associated with higher BMD that were also associated with higher odds
of rKOA. With this in mind we conducted genetic association analysis to
determine the relationship between these 56 BMD loci and radio-
graphic hip osteoarthritis (rHOA).
Methods: The current analysis was conducted on European-American
participants from the Osteoarthritis Initiative with genome wide gen-
otyping (Illumina 2.5 M array) and pelvis radiographs obtained at the
baseline and 48 month visits. Pelvis images were read for radiographic
features (IRFs) of hip OA using the OARSI atlas, and hips were classiﬁed
as deﬁnite rHOA (Croft grade2 or deﬁnite osteophytes or deﬁnite JSN),
possible rHOA (IRFs present but not deﬁnite, e.g. isolated grade 1
osteophyte or joint space narrowing) or normal. Cases had at least one
hip with deﬁnite rHOA at either time-point and hips replaced during
follow-up with an adjudicated diagnosis of OA or degenerative arthritis.
Controls had bilateral normal hips at baseline and, if radiographs were
available, at 48 month follow-up. Using these deﬁnitions we identiﬁed350 cases and 2294 controls with genotyping data for analysis. In two
sensitivity analyses we included subjects with possible RHOA as cases
and used as controls only those who had a 48-month pelvis ﬁlms.
Association analyses included adjustments for age, gender, BMI and
principal components to correct for ﬁne-scale population substructure.
Results:We identiﬁed one variant (rs7217932) near the SOX9 locus that
had a nominal association with rHOA (p ¼ 0.03, OR ¼ 1.20). The allele
associated with higher BMD was associated with higher odds of rHOA.
Of note, this variant was one of the few BMD loci associated with BMD
in the hip (femoral neck) but not the lumbar spine. The association did
not remain signiﬁcant when subjects with possible OAwere included as
cases (p ¼ 0.13, OR ¼ 1.10) but did when we required 48-month images
for controls (p ¼ 0.05 OR ¼ 1.18). None of the SNPs we identiﬁed from
our association analysis of rKOA were associated with rHOA (p > 0.05).
A BMD risk allele score based on 62 independent loci was not sig-
niﬁcantly associated with rHOA risk.
Conclusions: Despite a limited sample size we identiﬁed a nominal
association between a variant associated with femoral neck BMD and
rHOA, however this association does not remain signiﬁcant after
accounting for multiple testing. Replication analysis in additional
cohorts is needed to conﬁrm these ﬁndings, however the SOX9 locus
may play a role in osteoarthritis in addition to BMD at the hip.
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LSD1-MEDIATED DEMETHYLATION OF HISTONE H3 LYSINE 9
CONTRIBUTES TO INTERLEUKIN 1-INDUCED MICROSOMAL
PROSTAGLANDIN E SYNTHASE-1 EXPRESSION IN HUMAN
OSTEOARTHRITIC CHONDROCYTES
F-E. El Mansouri, S-S. Nebbaki, H. Aﬁf, M. Kapoor, J. Martrel-Pelletier,
J-P. Pelletier, M. Benderdour, H. Fahmi. CRCHUM, Univ. of Montreal,
Montreal, QC, Canada
Purpose: Microsomal prostaglandin E synthase-1 catalyzes the termi-
nal step in the biosynthesis of PGE2, which plays a critical role in the
pathophysiology of osteoarthritis. To investigate the role of histone H3
(H3K9) methylation in interleukin-1b (IL-1)-induced microsomal
prostaglandin E synthase-1 (mPGES-1) expression in human osteo-
arthritic (OA) chondrocytes.
Methods: Chondrocytes were stimulated with IL-1 and the expression
of mPGES-1mRNA was analyzed using real-time reverse transcriptase-
polymerase chain reaction. H3K9 methylation and the recruitment of
the histone demethylase LSD1 to the mPGES-1 promoter were eval-
uated using chromatin immunoprecipitation assays. The role of LSD1
was further evaluated using the the amino oxidase inhibitor tranylcy-
promine (a potent inhibitor of LSD1 activity).
Results: Treatment with IL-1 induced mPGES-1 expression in a time
dependent manner. The induction of mPGES-1 expression by IL-1 was
associated with H3K9 demethylation at the mPGES-1 promoter. These
changes were concomitant with the recruitment of the histone deme-
thylase LSD1. Treatment with tranylcypromine inhibited IL-1-induced
H3K9 demethylation as well as IL-1-induced mPGES-1 expression.
Conclusions: These results indicate that H3K9 demethylation by LSD1
contributes to IL-1-induced mPGES-1 expression and suggest that this
pathway could be a potential target for pharmacological intervention in
the treatment of OA and possibly other arthritic diseases.
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A CASE CONTROL STUDY TO EVALUATE THE ROLE OF GENETIC AND
ENVIRONMENTAL RISK FACTOR IN DEVELOPMENT AND
PROGRESSION OF OSTEOARTHRITIS KNEE
A. Mishra, D. Sanghi, A.C. Sharma, R.N. Srivastava. King George’s.Med.
Univ., Lucknow, India
Purpose: The present study was initiated to investigate the interaction
of SNPs in Estrogen receptor-a (ESR-a), Calmodulin-1 (CALM-1) and
Growth differentiation factor-5 (GDF-5) gene with osteoarthritis knee
(KOA); correlation of these genetic variants with envoirmnental factor
such as living standards and occupation.
Methodology: In a case-control study, 300 cases with KOA and an equal
number of age matched healthy controls were included. Cases were
diagnosed using the American College of Rheumatology (ACR) guide-
lines of knee osteoarthritis (KOA). Blood was drawn for genomic DNA
isolation; polymerase chain reaction coupled restriction fragments
length polymorphism (PCR-RFLP), TaqMan assay were carried out to
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mation and pair wise linkage disequilibrium between the SNPs) were
carried out using Haploview (www.broad.mit.edu/mpg/haploview/). All
statistical analysis was performed with the SPSS software package
(version 16.0 for windows; SPSS Chicago, IL).
Results: The variant genotype of ESR-a, CALM-1 and GDF-5 genes were
found to be present at relatively higher frequency in cases than in the
controls. Risk increased in cases that carried combination of variant
genotypes of ESR a (Btg-AA) and GDF-5 (TT); CALM-1 (ApeKI-TG) and
GDF-5 (TT); CALM-1(ApeKI-TG) and ESR a (Btg-AA) resulting in 4.00-
6.00 fold elevated risk to KOA. The haplotype C-G-G and T-G-G of ESR- a
gene reduced the risk to OA. In contrast the haplotype T-G-C containing
variant of all three polymorphism of CALM-1 genewas over represented
in the cases, increasing the risk to 3.5 fold (OR ¼ 3.49, 95% CI ¼ 1.67–
7.27, p ¼ 0.000). A signiﬁcant association of this variant genotype was
also found with clinical scores of KOA (VAS, WOMAC). Signiﬁcant
increased risk of TT than CC was found among moderate occupational
status, the risk of TT (OR¼ 2.07, 95% CI¼ 1.18-3.62, p¼ 0.01) was higher
than CC of GDF-5 (BsiE1) genotype among MIG living standard in cases
compared to controls. Likewise, ESR-a, Btg-I risk genotype also shows
signiﬁcant with moderate occupation (OR ¼ 2.34, 95% CI ¼ 1.26-4.33, p
¼ 0.007) and MIG living standard (OR ¼ 1.48 95% CI ¼ 1.01–2.19, p ¼
0.04). However, the risk of GT (OR¼ 3.15, 95% CI¼ 1.48–6.68, p¼ 0.003)
was signiﬁcantly higher than TT of ApeKI genotype among MIG living
standard in cases as compared to controls.
Conclusion: The results suggest that GDF-5, ESR-a and CALM-1 gene
polymorphism is associated with Knee OA and SNP-SNP interaction
inﬂuences the development of Knee OA. Likewise, association of these
SNP with clinical scores has again demonstrated that these genetic
markers could be effectively used for predicting development and
progression of osteoarthritis. Moderate occupation and MIG living
standard are higher prone to develop OA on the basis of GDF-5 and ESR-
a, Btg-I risk genotype. It may be hypothesized that the presence of
variant GDF-5 (BsiE1), ESR- a, Btg-I genotypes increases OA risk in
moderate occupation and MIG living standards in our population.
419
THE MTDNA HAPLOGROUPS ASSOCIATE WITH DIFFERENT
METHYLATION PATTERNS IN ARTICULAR CHONDROCYTES
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Purpose: To analyze the inﬂuence of the mitochondrial background on
the methylation patterns of articular chondrocytes
Methods: DNAmethylation proﬁling was performed using the Inﬁnium
HumanMethylation27 beadchip. Previously, cartilage isolated DNA from
41 cartilage samples (13 from haplogorup J, 20 from haplogroup H and 8
from haplogroups U) was bisulﬁte-modiﬁed using EZ DNA methylation
kit and hybridized according to the manufacturer’s instructions. DNA
methylation M-values were obtained and further compared between
haplogroups using ANOVA and adjusting for cofounder effects of age,
gender, disease status, and hospital origin. Post-hoc analysis was per-
formed for analysing haplogroup pairwise differences. Enrichment in
biological process and molecular function was tested by Gene set
enrichment analysis using a conditional hypergeometric test. All stat-
istical analyses were conducted in R software.
Results:ANOVAanalysis showeda total of1929CpGprobeswith ap-value
under 0.05 (Fig.1); post-hoc analysis of ANOVA allowed us to identify 560
signiﬁcant probes (adjusted p-value <0.05) between haplogroup H and
haplogroup J, 440 signiﬁcant CpGs for haplogroup H versus haplogroup U
comparison, and a total of 1084 signiﬁcant probes for the remaining
pairwise comparison (haplogroup J versus haplogroup U). Gene set
enrichment analysis showed a total of 38 biological processes and 3
molecular function processes signiﬁcantly altered. DNA damage response
(p-value 6.332061e-05), positive regulations of cell cycle process (p-value
2.491685e-06), RNA biosynthetic process (p-value 9.502843e-07) as well
as mitochondrial electron transport, NADH to ubiquinone (p-value
9.111800e-04) were enhanced in carriers of the mtDNA haplogroup J.
Conclusions: The genome-wide methylation analysis shows a distinct
epigenetic proﬁle in articular chondrocytes attending to their mito-
chondrial background. The role played by the mtDNA haplogroups onSpanish patients with OA could be mediated by this particular epi-
genetic proﬁle.
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VITAMIN D RECEPTOR GENE POLYMORPHISMS MODULATE THE
CLINICO-RADIOLOGICAL RESPONSE TO VITAMIN D
SUPPLEMENTATION IN KNEE OSTEOARTHRITIS
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Med. Coll., Bangalore, India; x Sanjay Gandhi Post Graduate Inst. of Med.
Sci., Lucknow, India
Purpose: Osteoarthritis (OA) is one of the most frequent causes of pain,
loss of function and disability in the elderly. Knee OA is particularly
common in Indian patients and there is currently no therapy that can
slow its progression. A beneﬁcial effect of vitamin D supplementation
on symptomatic improvement in OA knee patients has recently been
reported. Vitamin D receptor (VDR) gene plays an important role in
regulation of bone mass and in human articular chondrocytes of carti-
lage. In view of the importance of the vitamin D in bone development
the abnormalities in the VDR gene are viewed as potential contributors
to OA. Therefore, this study was planned as a pilot study to ﬁnd out to
whether the clinico-radiological response to vitamin D was modulated
by VDR gene polymorphisms.
Methods: This randomized placebo-controlled trial recruited 103 KOA
cases as per American College of Rheumatology (ACR) guideline having
vitamin D insufﬁciency (25(OH)D  50 nmol/L). Enrolled cases were
randomly allocated in two groups to receive placebo (51) and vitamin D
(52). Primary outcome measures: pain and functional disability which
were recorded by knee speciﬁc WOMAC index and secondary outcome
measurewere radiological features (joint spacewidth and osteophytes).
The serum levels of vitamin D were assessed by a method Enzyme
Linked Immunosorbent Assay using IDS, UK kit. Detection of VDR
polymorphisms (Taq1 & Apa I) were done by PCR-RFLP technique.
25(OH)D levels, clinical and radiological features were recorded at
baseline and at one year follow up.
Results: At one year, in vitamin D supplemented group, TT genotype of
TaqI polymorphism showed the maximum increment in the level of
25(OH)D in comparison to Tt and tt genotype whereas in placebo group
it remained same. No such association was observed for ApaI poly-
morphism. In clinical features, pain and functional disability improved
in each genotype although least in tt genotype in vitamin D supple-
mented group whereas in placebo group it signiﬁcantly worsened in Tt
and tt genotype. Total WOMAC scores improved in each genotype of
vitamin D supplemented group and was signiﬁcant in case of Tt and TT
